Usefulness of immunocytochemistry using a Breast Marker antibody cocktail targeting P63/cytokeratin7/18/cytokeratin5/14 for fine needle aspiration of the breast: a retrospective cohort study of 139 cases

Cytopathology ◽  
2016 ◽  
Vol 27 (6) ◽  
pp. 465-471 ◽  
Author(s):  
S. Tanaka ◽  
N. Kanomata ◽  
K. Teramura ◽  
K. Wakita ◽  
T. Kunihisa ◽  
...  
Keyword(s):  
Cohort Study ◽  
Fine Needle Aspiration ◽  
Retrospective Cohort Study ◽  
Retrospective Cohort ◽  
Needle Aspiration ◽  
Fine Needle ◽  
Antibody Cocktail

scholarly journals Risk of Malignancy in Thyroid Nodules with Non-Diagnostic Fine-Needle Aspiration: A Retrospective Cohort Study

Thyroid ◽  
2016 ◽  
Vol 26 (11) ◽  
pp. 1598-1604 ◽  
Author(s):  
Ana E. Espinosa De Ycaza ◽  
Kathleen M. Lowe ◽  
Diana S. Dean ◽  
M. Regina Castro ◽  
Vahab Fatourechi ◽  
...  
Keyword(s):  
Cohort Study ◽  
Fine Needle Aspiration ◽  
Retrospective Cohort Study ◽  
Retrospective Cohort ◽  
Thyroid Nodules ◽  
Needle Aspiration ◽  
Fine Needle ◽  
Risk Of Malignancy

scholarly journals The Utility of Repeat Endoscopic Ultrasound-Guided Fine Needle Aspiration for Suspected Pancreatic Cancer

2010 ◽  
Vol 2010 ◽  
pp. 1-4 ◽  
Author(s):  
Mark Nicaud ◽  
Wei Hou ◽  
Dennis Collins ◽  
Mihir S. Wagh ◽  
Shailendra Chauhan ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Cohort Study ◽  
Fine Needle Aspiration ◽  
Retrospective Cohort ◽  
Needle Aspiration ◽  
Pancreatic Mass ◽  
Reasonable Accuracy ◽  
Ultrasound Guided ◽  
Fine Needle ◽  
Diagnosis Of Cancer

Background. The utility of repeat EUS in patients with suspicion for pancreatic cancer after non-diagnostic EUS-FNA study is not well established.Aim. Determine the accuracy of repeat EUS-FNA in patients with suspected pancreatic cancer and prior non-diagnostic EUS-FNA.Methods. Retrospective cohort study.Results. From 2002 to 2008 in our institution 28 patients underwent repeat EUS-FNA for suspected pancreatic cancer. Initial EUS showed a pancreatic mass in 24 (85.71%), no mass in 3 (10.71%) and possible mass in 1 (3.58%). FNA was performed and was negative for malignancy in all patients. Repeat EUS showed pancreatic mass in 27 patients (96.42%) and no mass in 1 (3.58%). FNA was performed in all patients and cytology was positive for malignancy in 6 (21.43%). Out of the 28 patients, 17 (60.71%) were eventually confirmed to have cancer. Overall repeat EUS-FNA correctly determined the true final status in 17 out of 28 patients providing sensitivity for the diagnosis of cancer of 35% (95% CI 14%–62%), specificity 100% (95% CI 72%–100%), and overall accuracy of 61%, (95% CI 28%–72%).Conclusion. Repeat EUS-FNA provides reasonable accuracy and may be worthwhile in patients with suspected pancreatic cancer who had had prior negative EUS-FNA.

Sign in / Sign up

Export Citation Format

Share Document